The Charles Schwab Corporation vs Pfizer Inc.
Market cap comparison over time
The Charles Schwab Corporation
$160.4B
Rank #104
Pfizer Inc.
$164.5B
Rank #101
Market Cap Over Time
Key Moments
- The Charles Schwab Corporation overtook Pfizer Inc. by 2025
- Pfizer Inc. overtook The Charles Schwab Corporation by 2026
Year-by-Year Comparison
| Year | The Charles Schwab Corporation | Pfizer Inc. | Leader |
|---|---|---|---|
| 2026 | $160.4B | $164.5B | Pfizer Inc. |
| 2025 | $172.6B | $137.3B | The Charles Schwab Corporation |
| 2024 | $126.3B | $136.4B | Pfizer Inc. |
| 2023 | $115.7B | $139.5B | Pfizer Inc. |
| 2022 | $137.7B | $237.5B | Pfizer Inc. |
| 2021 | $137.5B | $265.1B | Pfizer Inc. |
| 2020 | $85.8B | $159.1B | Pfizer Inc. |
| 2019 | $75.6B | $154.3B | Pfizer Inc. |
| 2018 | $64.9B | $165.8B | Pfizer Inc. |
| 2017 | $79.6B | $132.8B | Pfizer Inc. |
| 2016 | $60.7B | $114.6B | Pfizer Inc. |
| 2015 | $50.2B | $109.7B | Pfizer Inc. |
| 2014 | $45.6B | $102.5B | Pfizer Inc. |
| 2013 | $38.9B | $97.3B | Pfizer Inc. |
| 2012 | $21.2B | $77.1B | Pfizer Inc. |
| 2011 | $16.4B | $64.0B | Pfizer Inc. |
| 2010 | $24.5B | $49.7B | Pfizer Inc. |
| 2009 | $26.5B | $49.6B | Pfizer Inc. |
| 2008 | $22.5B | $45.8B | Pfizer Inc. |
| 2007 | $35.1B | $55.2B | Pfizer Inc. |
| 2006 | $25.1B | $60.1B | Pfizer Inc. |
| 2005 | $18.9B | $52.1B | Pfizer Inc. |
| 2004 | $15.3B | $58.3B | Pfizer Inc. |
| 2003 | $15.0B | $75.0B | Pfizer Inc. |
| 2002 | $13.7B | $63.7B | Pfizer Inc. |
| 2001 | $19.4B | $81.9B | Pfizer Inc. |
| 2000 | $35.6B | $93.5B | Pfizer Inc. |
| 1999 | $31.9B | $65.4B | Pfizer Inc. |
| 1998 | $23.4B | $83.3B | Pfizer Inc. |
| 1997 | $11.6B | $49.3B | Pfizer Inc. |
| 1996 | $5.9B | $27.1B | Pfizer Inc. |
| 1995 | $3.7B | $20.2B | Pfizer Inc. |
| 1994 | $2.1B | $12.1B | Pfizer Inc. |